All Stories

  1. Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), December 2020, De Gruyter

    Yi-Qing Yang

  2. MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), September 2017, De Gruyter

    Yi-Qing Yang

  3. An update on the molecular diagnosis of congenital heart disease: focus on loss-of-function mutations

    Article • Expert Review of Molecular Diagnostics, March 2017, Taylor & Francis

    Yi-Qing Yang

  4. CASZ1 loss-of-function mutation contributes to familial dilated cardiomyopathy

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2017, De Gruyter

    Yi-Qing Yang

  5. TBX20 loss-of-function mutation associated with familial dilated cardiomyopathy

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2016, De Gruyter

    Yi-Qing Yang

  6. HAND1 loss-of-function mutation associated with familial dilated cardiomyopathy

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2016, De Gruyter

    Yi-Qing Yang